Genentech, Inc. Recall: Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc.,
Genentech, Inc. Recall: Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Genentech, Inc.; Product: Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64; Reason
| Recalling firm | Genentech, Inc. |
|---|---|
| Product | Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64 |
| Reason for recall | Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide within the United States |
| Recall initiated | 20240520 |
| Recall number | D-0509-2024 |
| Category | drug |
| State | CA |
| Country | United States |
$29/mo
Try RecallGuard →